---

Discussion

Priya Merlan:

It identifies a plausible population-health opportunity. Researchers modeled calories, saturated fat, salt and sugar, then used PRIME—the Preventable Risk Integrated Modelling Environment—to apply established risk relationships. That can show what might follow from a dietary shift. It cannot prove that a particular corporate strategy would prevent 150,000 deaths.

Kate Burvish:

And the intervention is easy to misunderstand. Products were ranked within categories using the Health Star Rating, and sales were shifted toward the healthier 50 percent. That could involve prices, shelf placement, advertising, procurement or reformulation. It may be more feasible than inventing entirely new product lines, but it still depends on affordability and incentives.

Ann Tofado:

The policy choice is not simply banning unhealthy food or leaving consumers alone. The report points toward corporate disclosure, healthy-sales targets, front-of-package labeling, marketing restrictions and fiscal or regulatory incentives. The political question is which combination can change the market rather than merely announce concern.

Red Velhouse:

Before asking consumers to carry that responsibility, how much do people actually care about healthy eating, and is caring the same as acting?

Kate Burvish:

Concern is widespread, but it competes with constraints at the moment of purchase. In a nationally representative Pew survey conducted in early 2025, 90 percent of adults said healthy food had become more expensive, and 69 percent said rising prices made it harder to eat healthily. Eighty-three percent considered taste a high priority, while about six in ten gave cost that level of importance. That is not indifference; it is a choice environment where taste and price often have more immediate force than healthfulness.

Priya Merlan:

A survey by the International Food Information Council found that taste influenced purchasing for 85 percent of respondents, price for 62 percent, healthfulness for 58 percent and convenience for 53 percent. Yet about 90 percent in a national Food Is Medicine survey agreed that eating more healthy food could improve health and prevent or manage disease. The obstacle is not simply knowledge. It is turning knowledge into behavior despite habits, limited time and practical barriers.

Kate Burvish:

Income makes that gap sharper. Seventy-seven percent of lower-income adults, compared with 54 percent of upper-income adults, said rising healthy-food prices made healthy eating harder. A household may prefer less sodium or more fiber, but preference has limited purchasing power if the product costs more, is unavailable nearby or takes longer to prepare. A less healthy purchase can reveal constraints as much as motivation.

Red Velhouse:

Does the picture change for people already living with diabetes, hypertension, cardiovascular disease or obesity?

Priya Merlan:

Often, yes, but not enough to make labels a complete solution. A nationally representative U.S. analysis found that people with hypertension, heart disease, diabetes or excess weight were generally more aware of dietary recommendations, checked specific nutrients more often and used food-label information more often than people without those conditions. A diagnosis can make sodium, carbohydrates or saturated fat personally urgent. But greater label use did not consistently translate into better adherence to dietary guidance.

Kate Burvish:

That distinction matters economically. Chronic disease can increase the value of information without increasing a household’s ability to pay. A patient may know which products fit a sodium or carbohydrate goal and still choose a cheaper alternative. Information reduces uncertainty; it does not reduce the price of the recommended food.

Ann Tofado:

It also argues against blaming either group. The general population may care but face an environment optimized for taste, convenience and sales. People with a diagnosis may be more attentive while facing more complicated choices and greater consequences when options are poor. A policy that assumes everyone will read, calculate and act correctly puts too much responsibility on individuals with the least room for error.

Red Velhouse:

The most familiar information policy is calorie posting on restaurant menus. What is the strongest conclusion we can responsibly draw about its effect?

Ann Tofado:

The strongest conclusion is that menu calorie labeling produces small average reductions in calories selected or purchased, with effects varying by setting. A 2025 Cochrane review covering more than 4.1 million purchase transactions and about 188,000 participants reported roughly a 9.5 percent reduction in energy purchased from labeled products. That pooled estimate included menus, packaged products and other settings, so it is not one universal estimate for every U.S. restaurant.

Priya Merlan:

For calories actually consumed, the evidence is weaker. In that review, an unlabeled 600-calorie meal corresponded on average to about 565 calories with labeling—roughly 35 fewer calories. Many studies were short laboratory experiments, and a purchase can be shared, partly eaten or offset later. A modest change at one meal is not evidence of reduced obesity or cardiovascular disease.

Kate Burvish:

Real-world transaction studies give a similar sense of scale. One large U.S. study of 2,329 fast-food restaurants estimated about 25 fewer calories purchased per transaction during the first two years after labeling, against a baseline of roughly 1,035 calories. Another found an initial reduction of about 60 calories, followed by a small weekly increase over the next year. Measurable, yes; a market transformation, no.

Red Velhouse:

Where do menu labels fit beside reformulation, front-of-package labels, healthier defaults and price incentives?

Ann Tofado:

They fit as supporting tools, not the backbone of the strategy. Reformulation changes food whether or not people read a label. Front-of-package labels make comparison faster. Healthier defaults change what is offered or placed most conveniently. Price incentives address affordability. Together, they reduce reliance on individual attention, although each depends on design and implementation.

Priya Merlan:

Reformulation has a medical advantage in reach. If a manufacturer reduces sodium or saturated fat in a widely purchased product, every purchaser receives that change, including people who never inspect a label. Reviews generally find mandatory targets more consistently effective than voluntary programs, although enforcement and design matter. Reformulation changes exposure upstream.

Kate Burvish:

Price incentives address a barrier labels leave untouched. Discounts, subsidies, coupons and produce-prescription programs can increase purchases of healthier foods, although effects vary with the size and duration of the incentive, where it can be used and what people substitute away from. Unlike a label, a price intervention changes purchasing power, which can make it more equitable but requires funding.

Red Velhouse:

Returning to the report, how much confidence should we place in its modeled health opportunity if consumer behavior is this complicated?

Priya Merlan:

The model identifies a plausible pathway, not a guaranteed response. Under its healthier-sales scenario, it estimates approximately 174 fewer calories per person per day, 7.1 grams less saturated fat, 1.5 grams less salt and 23.5 grams less sugar. Those changes could matter if sustained and actually consumed, but the model does not follow families through shopping, meals, compensation and treatment. A healthier product must replace something less healthy rather than simply be added or offset elsewhere.

Kate Burvish:

Coverage is another major constraint. The analysis used 9,724 products from 24 companies, representing about 37 percent of the packaged-food and beverage market by sales value in covered categories. Six categories were excluded, and restaurants, takeaways and cafés were left out even though out-of-home food supplies about 32 percent of calorie intake. This is a substantial opportunity, not a map of the entire food system. Product-level sales data were also unavailable, so estimated sales depended on assumptions about the mix of products.

Ann Tofado:

The sodium experience illustrates the implementation problem. The Food and Drug Administration’s sodium strategy remains largely voluntary and gradual. Phase I targets were finalized in 2021, and Phase II targets followed subsequently; implementation varies across companies and product categories. Existing evidence suggests reformulation can reduce sodium exposure, but progress has been uneven. Voluntary action can produce movement, but monitoring and credible pressure determine whether it continues.

Red Velhouse:

What should policymakers and the public watch next to tell us this is changing diets rather than merely changing the appearance of a product portfolio?

Priya Merlan:

Watch actual dietary exposure: sales-weighted sodium, calories, saturated fat and fiber; evidence of substitution; and, over time, blood pressure and disease outcomes. For people with chronic conditions, ask whether information helps them meet clinically relevant goals, not merely whether they saw a label. Labels can support care, but they cannot substitute for affordable options, clinical guidance or a healthier baseline food supply.

Kate Burvish:

Watch prices, market shares and who benefits. A healthier product gaining sales because it is affordable and widely available is different from a premium product gaining a small affluent audience. For incentives, measure whether purchases persist after discounts end and whether shoppers substitute toward other unhealthy products. For corporate commitments, measure actual revenue or units meeting the standard, not just the number of better-rated products.

Ann Tofado:

And watch whether policymakers claim more than the evidence supports. Menu calorie counts may produce small, meaningful changes for some transactions, but they are not a population-health solution by themselves. Reformulation, front-of-package labeling, healthier defaults and price incentives address different barriers. The strongest case is complementary: change products, improve affordability, simplify comparison and preserve useful information.

Priya Merlan:

The human conclusion is straightforward. Many people care about healthy food, and people living with diet-related conditions may care with greater urgency and use nutrition information more often. Neither fact guarantees a healthy diet when choices are expensive, inconvenient, confusing or built around familiar taste. Better environments can make individual effort more effective.

Kate Burvish:

The economic conclusion is that behavior should not be mistaken for unconstrained demand. If healthier food costs more or requires more time, purchases reveal constraints as much as preferences. The report is provocative because it treats company portfolios as a lever, but moving that lever requires incentives that make healthier products affordable, visible and commercially viable at meaningful volume.

Ann Tofado:

The political conclusion is that information-only policies are attractive because they leave responsibility with the individual. A more credible approach distributes responsibility: companies change products, retailers and institutions change defaults and availability, government sets standards and incentives, and consumers receive usable information. That is more demanding than posting a number, but it better matches how eating decisions happen.

Red Velhouse:

The unresolved issue is whether a modeled shift toward healthier existing products can become a sustained, affordable, sales-weighted change across a market the study only partly covers. The public largely says healthy eating matters, but taste, price, convenience and access shape what people can repeatedly do. People with diet-related conditions often use nutrition information more, yet labels alone do not reliably produce better diets. Menu calorie counts can yield small reductions in calories purchased, but the evidence is weaker for consumption and does not show that posting numbers alone changes long-term disease outcomes. Watch independent scrutiny of the assumptions, company disclosures tied to actual sales, price and substitution data, progress under sodium targets, and evidence of changes in blood pressure and diet—not just product ratings. Sources and references for this discussion are available with the episode at Factolio.com.

---

Sources and References

These sources supported the factual material used in this discussion. Factolio’s panel discussion is AI-generated from researched evidence and is written in original language.

1. Access to Nutrition Initiative and ShareAction — Existing canonical source: U.S. healthier packaged-food sales modeling report (ANALYSIS)
2. Access to Nutrition Initiative and ShareAction — Existing canonical report and methodology (ANALYSIS)
3. Access to Nutrition Initiative and ShareAction — Existing technical methodology and limitations source (PRIMARY)
4. University of Oxford / PRIME — PRIME population health-impact modeling framework (PRIMARY)
5. U.S. Food and Drug Administration — FDA sodium-reduction guidance and targets (PRIMARY)
6. Pew Research Center — Existing canonical source: 2025 U.S. survey on healthy-food prices and eating (DATA)
7. International Food Information Council — Existing canonical source: 2024 Food and Health Survey (DATA)
8. Health Affairs — Existing canonical source: 2023 Food Is Medicine survey (DATA)
9. Existing canonical review source — Healthier defaults and food-environment interventions (ANALYSIS)
10. Existing canonical review source — Price incentives and healthy-food purchasing (ANALYSIS)
11. Existing canonical review source — Produce prescriptions and healthy-food affordability interventions (ANALYSIS)
12. Cochrane Collaboration — Calorie (energy) labelling for changing selection and consumption of food or alcohol, 2025 review (PRIMARY)
13. JAMA Network Open — Menu Labeling and Calories Purchased in Restaurants in a US National Fast Food Chain (PRIMARY)
14. BMJ — Estimating the effect of calorie menu labeling on calories purchased in a large restaurant franchise in the southern United States: quasi-experimental study (PRIMARY)
15. American Journal of Clinical Nutrition / CDC Stacks — Dietary information use among persons with chronic disease: nationally representative U.S. analysis (PRIMARY)
16. Centers for Disease Control and Prevention, Preventing Chronic Disease — Health status and nutrition label use among U.S. adults (PRIMARY)
17. Public Health Nutrition — Diabetes diagnosis and nutrition facts label use among US adults, 2005–2010 (PRIMARY)
18. Systematic Review, Journal of Human Nutrition and Dietetics — The relationship between food label use and dietary intake in adults (ANALYSIS)
19. Journal of Human Nutrition and Dietetics — Health literacy, literacy, numeracy and nutrition label understanding and use: a scoping review (ANALYSIS)
20. Systematic Review, PubMed — Effect of front-of-package nutrition labeling on food purchases (ANALYSIS)
21. Centers for Disease Control and Prevention, Preventing Chronic Disease — Pricing Strategies to Encourage Availability, Purchase, and Consumption of Healthy Foods and Beverages: A Systematic Review (ANALYSIS)
22. Systematic review — Front-of-Package Nutrition Labeling and Its Impact on Food Industry Practices: A Systematic Review of the Evidence (ANALYSIS)